Kriti Nutrients Ltd (KRITINUT)
🎯 Key Takeaways
- Kriti Nutrients Ltd appears to be in a stable growth phase, leveraging consistent operational improvements to drive profitability while maintaining a conservative capital structure. The company has demonstrated steady revenue expansion and margin resilience, supported by strong promoter backing and minimal external financing.
- Revenue declined 3.2% QoQ to ₹247 in Q1FY27.
- ⚠️ Overreliance on a single business segment or customer base, as no diversification or new product launches were mentioned in the filings.
- Market Cap
- ₹366
- P/E Ratio
- 10.9
- P/B Ratio
- 1.60
- ROE
- 14.6%
- ROCE
- 19.3%
- Debt/Equity
- 0.03
- Div Yield
- 4.11%
- Promoter
- 66.7%
📖 The Story
Kriti Nutrients Ltd appears to be in a stable growth phase, leveraging consistent operational improvements to drive profitability while maintaining a conservative capital structure. The company has demonstrated steady revenue expansion and margin resilience, supported by strong promoter backing and minimal external financing. Its focus on governance and shareholder returns, including regular dividend payouts, reinforces a disciplined management approach. However, limited institutional interest and stagnant promoter stake suggest limited upside catalysts in the near term.
📰 What's Happening
In Q1 FY27 (June 2026), Kriti Nutrients reported consolidated revenue of ₹2,487.51 lakhs, up from ₹2,310.88 lakhs YoY, with net profit rising to ₹905.66 lakhs. The board approved these unaudited results on August 11, 2026, following an unmodified audit opinion from M Mehta & Co, confirming no material misstatements. At the 30th AGM on August 12, 2026, shareholders reappointed Saurabh Singh Mehta as director and M Mehta & Co as auditors for another five-year term. The company also declared an interim dividend of ₹3.00 per share (300%) and approved revised remuneration for Whole-time Directors, effective August 1, 2026, subject to shareholder approval and a cap of 5% of net profits under Schedule V of the Companies Act, 2013.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 213 | 224 | 255 | 247 |
| Operating Profit | 10 | 10 | 8 | 10 |
| OPM % | 4.6% | 4.5% | 3.1% | 4.2% |
| Net Profit | 9 | 9 | 6 | 9 |
| EPS | ₹1.78 | ₹1.83 | ₹1.27 | ₹1.78 |
Revenue has shown sequential and YoY growth, rising to ₹2,487.51 lakhs in Q1 FY27 from ₹2,310.88 lakhs in the same quarter last year, with operating performance improving from ₹10 lakhs in Q4 FY26 to ₹10 lakhs in Q1 FY27 despite lower revenue in prior quarters. Operating margins remain stable around 4%, while net profit margins have expanded, supported by cost discipline. EPS of ₹1.78 in Q1 FY27 reflects improved profitability, up from ₹1.27 in Q4 FY26 and ₹1.78 in Q3 FY26, indicating consistent earnings momentum. The company has maintained stable margins even during seasonal fluctuations, suggesting operational resilience.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance on revenue or margin expectations in the latest filings. However, the reappointment of key personnel and approval of director remuneration adjustments signal confidence in sustained governance and operational continuity. The company emphasized adherence to regulatory requirements, including SEBI-mandated trading windows and electronic voting compliance for its AGM. While no growth targets were disclosed, the focus remains on executing its core business with an emphasis on financial discipline and shareholder transparency.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2024 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 |
| Reserves | 171 | 207 | 224 | 224 |
| Borrowings | 12 | 3 | 8 | 6 |
| Total Liabilities | 209 | 238 | 273 | 256 |
| Fixed Assets | 58 | 57 | 57 | 56 |
| Investments | 12 | 45 | 55 | 51 |
| Total Assets | 209 | 238 | 273 | 256 |
The balance sheet reflects a strong equity base of ₹5 lakhs and growing reserves of ₹224 lakhs as of March 2026, with negligible borrowings of just ₹8 lakhs, indicating a near-debt-free structure. Total assets have risen to ₹273 lakhs from ₹256 lakhs in the prior year, driven by operational growth. The company has consistently maintained low leverage, with borrowings declining from ₹6 to ₹3 lakhs over two years, suggesting prudent capital management and a preference for internal funding over external debt.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +64 |
| Investing | -9 |
| Financing | -10 |
| Net Cash Flow | +45 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 66.7% | 66.7% | 66.7% | 66.7% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 19.4% | 19.2% | 19.4% | 19.1% |
| # Shareholders | 20,831 | 20,753 | 20,231 | 19,592 |
Promoter holding remains stable at 66.68% across all recent quarters, reflecting strong control and confidence. Institutional ownership is virtually absent, with FII and DII holdings at 0% and 0.03% respectively in Q1 FY27, down slightly from 0.02% in Q4 FY26. The number of public shareholders has declined marginally from 20,831 to 19,592, suggesting possible consolidation. There are no signs of institutional accumulation, and the lack of foreign or domestic institutional interest may limit liquidity and analyst coverage.
⚖️ Peer Comparison — FMCG
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| HINDUNILVR | 4.39 L Cr | 29.3 | 29.8% | — | 0.00 |
| ITC | 3.32 L Cr | 16.7 | 36.0% | — | 0.03 |
| NESTLEIND | 2.58 L Cr | 67.6 | 99.2% | — | 0.00 |
| VBL | 1.45 L Cr | 43.0 | 21.5% | — | 0.10 |
| LENSKART | 1.17 L Cr | 176.0 | 11.9% | — | 0.03 |
| BRITANNIA | 1.16 L Cr | 44.7 | 54.1% | — | 0.27 |
| MARICO | 1.03 L Cr | 54.4 | 54.2% | — | 0.08 |
| TATACONSUM | 95,699 | 58.5 | 10.2% | — | 0.10 |
| GODREJCP | 87,631 | 45.8 | 17.8% | — | 0.33 |
| DABUR | 67,419 | 34.2 | 21.3% | — | 0.09 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Overreliance on a single business segment or customer base, as no diversification or new product launches were mentioned in the filings. 2. Limited institutional investor interest may lead to lower liquidity and increased volatility. 3. Governance risks tied to promoter dominance and minimal shareholder activism, given only 19,592 public shareholders. 4. Compensation adjustments for Whole-time Directors exceeding 5% of net profits could pressure margins if not managed carefully, especially in a soft demand environment.
📋 Recent Filings
- Financial Results2026-09-28Kriti Nutrients Ltd announced the closure of its insider trading window from October 1, 2026, until 48 hours after the release of unaudited standalone…
- 🟡 Board Meeting2026-09-09The 30th Annual General Meeting of Kriti Nutrients Ltd was held on 12 August 2026 via video conferencing. All resolutions including adoption of audite…
- 🟡 Board Meeting2026-08-12Kriti Nutrients Limited held its 30th Annual General Meeting on 12 August 2026 via video conferencing, with 49 members attending, including directors …
- 🔴 Financial Results2026-08-11Kriti Nutrients Limited reported unaudited standalone revenue of ₹2,487.51 lakhs and consolidated revenue of ₹2,487.51 lakhs for the quarter ended Jun…
- 🟡 Board Meeting2026-08-11Kriti Nutrients Limited announced the outcome of its August 11, 2026 board meeting, approving unaudited standalone and consolidated financial results …
- Announcement2026-07-21Kriti Nutrients Limited announced it dispatched letters to shareholders who have not registered their email addresses, providing a link to access the …
- 🟡 Board Meeting2026-07-21Kriti Nutrients Limited announced remote and electronic voting facilities for its 30th Annual General Meeting scheduled for Wednesday, 12th August 202…
- 🔴 annual report2026-07-21Kriti Nutrients Limited announced its 30th Annual General Meeting to be held on 12th August 2026 via video conferencing. Shareholders will vote on ado…
- share transfer2026-07-13Kriti Nutrients Limited received a SEBI-mandated compliance certificate for the quarter ending 30 June 2026, confirming that dematerialized securities…
- Financial Results2026-06-23Kriti Nutrients Limited announced that its trading window for shares will remain closed from 1 July 2026 until 48 hours after the release of unaudited…
🧠 Analyst's Read
Kriti Nutrients is executing a stable, capital-efficient business with consistent profitability and strong promoter backing, but lacks catalysts for meaningful re-rating. Investors should monitor the outcome of the special resolution on director remuneration and any future commentary on growth strategy during the next earnings cycle. The absence of institutional interest and stagnant promoter stake suggest limited upside, making the stock suitable for long-term holders seeking steady returns rather than aggressive growth.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when KRITINUT files new disclosures
Track KRITINUT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track KRITINUT — FreeFree account · 2 AI queries/day